📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Novasep

1.1 - Company Overview

Novasep Logo

Novasep

Headquarter: France
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of contract development and manufacturing services for active pharmaceutical ingredients (APIs) and biopharmaceuticals, covering process development, scale-up and commercial cGMP production. Offers lipid synthesis and purification (including lipid nanoparticles for RNA therapies), industrial chromatography for API/biomolecule purification, specialized steroid and high-potent API manufacturing, and small-molecule API production including custom development for large-volume molecules.

Products and services

  • Chromatography: Engineers industrial chromatography assemblies for purification of APIs and biomolecules, offering a wide range of chromatographic techniques, industrial-scale
  • Novasep CDMO: Delivers contract development and manufacturing services for small‑molecule APIs and biopharmaceuticals, ensuring a secured supply chain with cGMP manufacturing assets, cGMP-compliant
  • Lipid Production: Fabricates lipids and performs purification for pharmaceutical use, including lipid nanoparticles for RNA-based therapies, under cGMP conditions, cGMP-compliant

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Novasep

Pharmaceutics International Logo

Pharmaceutics International

HQ: United States Website
  • Description: Provider of science-driven contract development and manufacturing services, offering formulation development and clinical trial manufacturing for drugs and biologics; solubility/bioavailability enhancement; lyophilization formulation and cycle development with GMP scale-up; fill-finish development and aseptic fill-finish for vials, syringes, and cartridges; and ready-to-use 3mL cartridges for consistent delivery of high-viscosity, high concentration injectables.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pharmaceutics International company profile →
Continuum Clinical Logo

Continuum Clinical

HQ: United States Website
  • Description: Provider of Health Economics and Outcomes Research services and clinical trial engagement solutions, including the MERIS Total Engagement suite for participant and site support with real-time performance data; patient recruitment campaigns; Global Site Solutions; study/site support; retention solutions; and patient advocacy and diversity & inclusion services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Continuum Clinical company profile →
Syner-G BioPharma Logo

Syner-G BioPharma

HQ: United States Website
  • Description: Provider of pharmaceutical development and CMC solutions; cGMP and quality/compliance services; regulatory strategy and submissions spanning CMC, nonclinical, and clinical; functional outsourcing partnerships with dedicated regulatory staff; medical writing for scientifically accurate, compliant documents; and CMC consulting focused on strategy, compliance, and process optimization in drug development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Syner-G BioPharma company profile →
IPA Logo

IPA

HQ: Canada Website
  • Description: Provider of bioplatform-based, AI-driven antibody discovery and development services leveraging systems biology and multi-omics modeling. Offerings include target analysis and immunization, antibody discovery and characterization (sequencing and custom assays), developability profiling, and optimization/engineering (humanization, affinity maturation, chimerization). Includes LENSai Integrated Intelligence Technology for drug discovery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full IPA company profile →
Inkemia Logo

Inkemia

HQ: Spain Website
  • Description: Provider of high technological value knowledge generation, management and exploitation to support industries in the field of life sciences, focusing on creating and leveraging knowledge rather than being an industrial company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Inkemia company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Novasep

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Novasep

2.2 - Growth funds investing in similar companies to Novasep

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Novasep

4.2 - Public trading comparable groups for Novasep

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Novasep

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Novasep

What does Novasep do?

Novasep is a provider of contract development and manufacturing services for active pharmaceutical ingredients (APIs) and biopharmaceuticals, covering process development, scale-up and commercial cGMP production. Offers lipid synthesis and purification (including lipid nanoparticles for RNA therapies), industrial chromatography for API/biomolecule purification, specialized steroid and high-potent API manufacturing, and small-molecule API production including custom development for large-volume molecules.

Who are Novasep's competitors?

Novasep's competitors and similar companies include Pharmaceutics International, Continuum Clinical, Syner-G BioPharma, IPA, and Inkemia.

Where is Novasep headquartered?

Novasep is headquartered in France.

How many employees does Novasep have?

Novasep has 1,000 employees 🔒.

When was Novasep founded?

Novasep was founded in 2010 🔒.

What sector and industry vertical is Novasep in?

Novasep is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Novasep

Who are the top strategic acquirers in Novasep's sector and industry

Top strategic M&A buyers and acquirers in Novasep's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Novasep?

Top strategic M&A buyers groups and sectors for Novasep include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Novasep's sector and industry vertical

Which are the top PE firms investing in Novasep's sector and industry vertical?

Top PE firms investing in Novasep's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Novasep's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Novasep's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Novasep's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Novasep include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Novasep's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Novasep?

The key public trading comparables and valuation benchmarks for Novasep include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Novasep for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Novasep with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Novasep's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Novasep with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Novasep's' sector and industry vertical?

Access recent funding rounds and capital raises in Novasep's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Novasep